Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder - Related Studies

Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder

This study is currently recruiting participants.

Study NCT00429273. Last updated on October 24, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Additional conditions recognized in this trial
		Attention Deficit Disorder with Hyperactivity
		Disease
		Hyperkinesis

2	More general conditions related to this trial
		Attention Deficit and Disruptive Behavior Disorders
		Dyskinesias
		Mental Disorders
		Mental Disorders Diagnosed in Childhood
		Nervous System Diseases
		Neurologic Manifestations
		Pathologic Processes
		Signs and Symptoms

3	Interventions listed in this trial
		Guanfacine
		Methylphenidate (MPH)

4	Additional drug interventions recognized in this trial
		Methylphenidate

5	More general drug interventions related to this trial
		Adrenergic Agents
		Adrenergic Agonists
		Adrenergic alpha-Agonists
		Antihypertensive Agents
		Cardiovascular Agents
		Central Nervous System Agents
		Central Nervous System Stimulants
		Dopamine Agents
		Dopamine Uptake Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Neurotransmitter Uptake Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)